13 Jul 17

Biontech, Siemens enter strategic collaboration on produce of personalized cancer vaccines BioNTech and Siemens AG, a completely integrated biotechnology firm developing truly personalized malignancy immunotherapies, have entered right into a strategic collaboration erectile dysfunction drugs . BioNTech AG's subsidiaries, BioNTech RNA Pharmaceuticals EUFETS and GmbH GmbH, will work as well as Siemens on the structure of a completely automated and digitalized creation site to supply capacity for BioNTech's personalized malignancy vaccines to serve worldwide marketplaces truly.